Status:
COMPLETED
Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of ...
Eligibility Criteria
Inclusion
- Male or female of African descent
- 40 years of age or older
- Diagnosis of COPD
- History of smoking at least one pack per day for at least 10 years
- Currently experiencing shortness of breath at least with exertion
Exclusion
- Asthma
- Recent myocardial infarction or hospitalization for congestive heart failure
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT00106821
Start Date
June 1 2004
Last Update
November 1 2013
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigational Site
Birmingham, Alabama, United States
2
Cooper Green Hospital
Birmingham, Alabama, United States
3
University of Alabama at Birmingham
Birmingham, Alabama, United States
4
David Geffen School of Medicine
Los Angeles, California, United States